International Business Machines Corp

NYSE: IBM
$204.99
-$4.00 (-1.9%)
Closing Price on November 15, 2024

IBM Articles

The turnaround at IBM has faltered, flailed and failed. Here are a few of the most likely candidates to IBM CEO Ginni Rometty.
It seems IBM cannot turn itself around, but it is good at press releases that say little or nothing about the company's prospects.
General Electric can't seem to shake its position as the worst performing DJIA stock of 2017. Even some good words from analysts weren't enough.
It turns out that it can be quite simple for a great company to fall from grace. Once a company stays out of the spotlight for some time, the public and investors may cease to care what the company...
24/7 Wall St. recently featured IBM as one of 11 great American companies that have lost their narrative. It almost no longer matters what management says or does.
Here 24/7 Wall St. features 11 great American companies that have all lost their own narratives. They were great before, but not now.
GE, DryShips, IBM, and U.S. Silica all posted new 52-week lows on Friday.
IBM, AT&T, DryShips, and BBVA Banco Francés all posted new 52-week lows Wednesday.
Stocks were indicated to open only slightly higher on Wednesday after a mixed bag of corporate earnings. What investors need to understand is that the major equity indexes remain just under all-time...
IBM (NYSE: IBM) posted its 21st consecutive quarter of falling revenue, a breathtakingly poor performance. IBM’s board should do now what it should have done long ago: replace CEO Ginni Rometty....
IBM misses revenue estimates; Google plans to relaunch Google Glass; Chipotle faces another food-poisoning outbreak.
International Business Machines Corp. (NYSE: IBM) reported its most recent quarterly results after the markets closed on Tuesday. Big Blue said that it had $2.97 in earnings per share (EPS) and $19.3...
International Business Machines Corp. (NYSE: IBM) is scheduled to release its most recent quarterly results after the markets close on Tuesday. Consensus estimates from Thomson Reuters are calling...
IBM, JPMorgan, Pfizer, and Merck were the poorest performing stocks among the Dow 30 on Monday.
Trian launches proxy fight against Procter & Gamble, China's GDP grew faster than expected in the second quarter, IBM released a new series of computer products.